Computational investigation of the binding of a designed peptide to λ light chain amyloid fibril

Computational investigation of the binding of a designed peptide to λ light chain amyloid fibril

Systemic mild chain amyloidosis (AL) causes a malignant pathology related to the formation of amyloid fibrils that deposit in human organs and tissues, resulting in dysfunction and extreme morbidity. Amyloid fibril-reactive antibodies have been used to take away amyloid from organs and are efficient in restoring organ perform in sufferers with AL amyloidosis. Sadly, antibodies don’t bind amyloid in…

Read More